Document is current
Any future updates will be listed below
-
Authors
Michel, Maike https://orcid.org/0000-0002-1011-8673
Fiebich, Bernd L.
Kuzior, Hanna
Meixensberger, Sophie
Berger, Benjamin
Maier, Simon
Nickel, Kathrin
Runge, Kimon
Denzel, Dominik
Pankratz, Benjamin
Schiele, Miriam A.
Domschke, Katharina
van Elst, Ludger Tebartz
Endres, Dominique https://orcid.org/0000-0001-7322-1195
-
Funding
Funding for this research was provided by:
Albert-Ludwigs-Universität Freiburg
Ministry of Science, Research and the Arts of Baden-Württemberg
- License Information
-
More Information
Article History
Received: 11 February 2021
Revised: 26 March 2021
Accepted: 5 May 2021
First Online: 21 May 2021
Conflict of interest
: B.B. received travel grants and/or training expenses from Bayer Vital GmbH, Ipsen Pharma GmbH, Norvartis, Biogen GmbH, and Genzyme, as well as lecture fees from Ipsen Pharma GmbH, Alexion Pharma GmbH, Merck, Sanofi Genzyme, and Roche. K.D. is a member of the Steering Committee Neurosciences, Janssen. L.T.v.E. received compensation for advisory boards, lectures, or travel within the last 3 years from Roche, Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen, and Cyberonics. All other authors declare that they have no potential conflicts of interest.
